VIKING GLOBAL PERFORMANCE LLC's Net Worth
$22 Million
Who is VIKING GLOBAL PERFORMANCE LLC?
VIKING GLOBAL PERFORMANCE LLC has an estimated net worth of $22 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Editas Medicine, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Wayfair Inc., Urovant Sciences Ltd., Axovant Sciences Ltd., FIRST DATA CORP, APi Group Corp, IMCLONE SYSTEMS INC, and BridgeBio Pharma, Inc..
SEC CIK
VIKING GLOBAL PERFORMANCE LLC's CIK is 0001132625
Past Insider Trading and Trends
2015 was VIKING GLOBAL PERFORMANCE LLC's most active year for acquiring shares with 12 total transactions. VIKING GLOBAL PERFORMANCE LLC's most active month to acquire stocks was the month of January. 2016 was VIKING GLOBAL PERFORMANCE LLC's most active year for disposing of shares, totalling 2 transactions. VIKING GLOBAL PERFORMANCE LLC's most active month to dispose stocks was the month of January. 2015 saw VIKING GLOBAL PERFORMANCE LLC paying a total of $0.00 for 5,459,616 shares, this is the most they've acquired in one year. In 2016 VIKING GLOBAL PERFORMANCE LLC cashed out on 8,888,888 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.00M |
$55.65 | -$55,650,000.00 | 29.99M |
Dec 14
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIRST DATA CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 43.5M |
—
|
—
| 43.5M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APi Group Corp (APG) Snapshot price: $32.82
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.95M |
$38.15 | -$74,460,483.30 |
0
|
Jun 17
| |||
Form 4
| -60.89% | -3.04M |
$34.25 | -$104,072,632.25 | 1.95M |
Mar 5
| |||
Form 4
| +41.73% | 4.14M |
$30.75 | $51,741,659.70 | 14.05M |
Feb 28
| |||
Form 4
| -18.90% | -6.50M |
$31.30 | -$203,450,000.00 | 27.89M |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 4
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||